Item 7.01 Regulation FD Disclosure.

BioLargo, Inc., intends to present the slides attached as Exhibit 99.1, which are incorporated herein by reference, at its annual meeting on June 2, 2022, at 10:00 a.m. Pacific Time.

The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01, and in the slide presentation attached as Exhibit 99.1 to this Current Report shall not be incorporated by reference into any filing with the SEC made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The Company undertakes no duty or obligation to update or revise the information contained in this report, although it may do so from time to time as its management believes is appropriate. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosures. For important information about forward looking statements, see the information under the heading "Safe Harbor Act" on the first slide under the heading "Safe Harbor Statement" in Exhibit 99.1 attached hereto.

Item 9.01. Financial Statements and Exhibits.



(d)     Exhibits.


Exhibit No.                   Description
99.1                            Presentation slides
104                           Cover Page Interactive Data File (embedded within
                              the Inline XBRL document)

© Edgar Online, source Glimpses